These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7121012)
1. A small animal model for monitoring inotropic responses to cardiotonic agents. Beek OG J Pharmacol Methods; 1982 Jun; 7(4):321-9. PubMed ID: 7121012 [TBL] [Abstract][Full Text] [Related]
2. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs. Lin BB; Chen HL Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related]
4. Optimising conditions for studying the acute effects of drugs on indices of cardiac contractility and on haemodynamics in anaesthetized guinea pigs. Mooney L; Marks L; Philp KL; Skinner M; Coker SJ; Currie S J Pharmacol Toxicol Methods; 2012 Jul; 66(1):43-51. PubMed ID: 22659057 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular profile of Ro 13-6438, a novel positive inotropic agent with vasodilating properties. Eigenmann R; Gerold M; Holck M J Cardiovasc Pharmacol; 1984; 6(3):511-9. PubMed ID: 6202980 [TBL] [Abstract][Full Text] [Related]
6. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization. Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities. Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023 [TBL] [Abstract][Full Text] [Related]
8. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations. Furukawa Y; Akahane K; Haniuda M; Chiba S Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190 [TBL] [Abstract][Full Text] [Related]
9. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations. Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties. Mochizuki N; Uchida S; Miyata H J Cardiovasc Pharmacol; 1993 Jun; 21(6):983-95. PubMed ID: 7687727 [TBL] [Abstract][Full Text] [Related]
11. Comparison of some new positive inotropic agents in guinea pigs. van Meel JC Pharmacology; 1985; 31(1):1-10. PubMed ID: 3161096 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205. Roebel LE; Dage RC; Cheng HC; Woodward JK J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the pharmacological effects of inotropic drugs on left ventricular pressure and contractility: an evaluation of the QA interval as an indirect indicator of cardiac inotropism. Norton K; Iacono G; Vezina M J Pharmacol Toxicol Methods; 2009; 60(2):193-7. PubMed ID: 19523528 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one). Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a method to correct the contractility index LVdP/dt(max) for changes in heart rate. Markert M; Trautmann T; Groß M; Ege A; Mayer K; Guth B J Pharmacol Toxicol Methods; 2012 Sep; 66(2):98-105. PubMed ID: 22554385 [TBL] [Abstract][Full Text] [Related]
17. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs. Pagel PS; Hettrick DA; Warltier DC Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755 [TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), in conscious and anesthetized dogs. Miyazaki S; Sasayama S; Nakamura Y; Kihara Y; Susawa T; Kawai C J Cardiovasc Pharmacol; 1986; 8(1):14-20. PubMed ID: 2419676 [TBL] [Abstract][Full Text] [Related]
19. Influence of acidosis on cardiotonic effects of milrinone. Tanaka M; Ishikawa T; Nishikawa T; Goto K; Sato S Anesthesiology; 1998 Mar; 88(3):725-34. PubMed ID: 9523817 [TBL] [Abstract][Full Text] [Related]
20. Relationship between cardiotonic effects and inhibition on cardiac sarcolemmal Na+,K+-ATPase of strophan-thidin at low concentrations. Su SW; Wang YL; Li JX; Mei HS; Yin JX Acta Pharmacol Sin; 2003 Nov; 24(11):1103-7. PubMed ID: 14627493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]